Cargando…
Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study
Patients with unresectable and advanced intrahepatic cholangiocarcinoma (ICC) usually have short survival due to a lack of effective treatment. This multicenter, single arm, open labeled, prospective study was conducted to evaluate the effectiveness and safety of sorafenib combined with best support...
Autores principales: | Luo, Xiangji, Jia, Weidong, Huang, Zhiyong, Li, Xiangcheng, Xing, Baocai, Jiang, Xiaoqing, Li, Jun, Si, Anfeng, Yang, Tian, Gao, Chunfang, Lau, Wan Yee, Shen, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370037/ https://www.ncbi.nlm.nih.gov/pubmed/27783997 http://dx.doi.org/10.18632/oncotarget.12825 |
Ejemplares similares
-
Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma
por: Si, Anfeng, et al.
Publicado: (2017) -
Efficacy and Safety of Apatinib in Treatment of Unresectable Intrahepatic Cholangiocarcinoma: An Observational Study
por: Hu, Yubin, et al.
Publicado: (2020) -
Safety and initial efficacy of ablative radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma
por: Paz-Fumagalli, Ricardo, et al.
Publicado: (2021) -
Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling
por: Gruttadauria, Salvatore, et al.
Publicado: (2021) -
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study
por: Mosconi, Cristina, et al.
Publicado: (2016)